Really highlights the potential of Travelan. $100M in sales is very possible given that it's the only effective drug that prevents TD, and without any side effects. This company is just absurdly undervalued. I believe the company is worth at least 5X the current market cap alone solely based on the traveler's diarrhea indication.
Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-5
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 51067 | 1 |
View Market Depth
| Last trade - 16.12pm 03/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |
Day chart unavailable